Purchase Order 75N91024P00519
Award Date 9/16/24
Potential Completion Date 1/15/27
Potential Value $700K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a $19.71K firm fixed price Blanket Purchase Agreement (BPA) call by the National Cancer Institute (NCI) for maintenance and preventative maintenance services on a government-owned flow cytometry system located in Bethesda, Maryland. The contract, awarded April 1, 2022, with an ultimate completion date of March 31, 2023, requires the contractor to provide all labor, material, and equipment...
- The National Cancer Institute awarded a $17,928 firm fixed price Blanket Purchase Agreement (BPA) call to Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, for maintenance services on flow cytometry equipment. The contract, awarded on May 21, 2021, with an ultimate completion date of May 20, 2022, supports the Environmental Imaging and Biomedical Instrumentation (EIB) facility in Bethesda, Maryland. The maintenance services are intended to enable emergency...
- The National Cancer Institute awarded a Blanket Purchase Agreement (BPA) call to Becton, Dickinson and Company (BD), through its BD Biosciences division, for a one-year maintenance agreement on a FACSCalibur 4 CLR/Sort flow cytometry instrument (Serial #E4950). The contract, valued at $13,235.40 with a fixed-price structure including economic price adjustment provisions, was awarded on February 7, 2015, for performance at NCI facilities in Bethesda, Maryland. This call represents maintenance and...
- This is a $1,994,840.77 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The contract is for maintenance services on various government-owned BD flow cytometry equipment over the base period ending on July 1, 2026. BD is a global medical technology company that specializes in flow cytometry, cell imaging, and...
- The National Cancer Institute (NCI), a component of the National Institutes of Health under the Department of Health and Human Services, awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), through its BD Biosciences division, for preventive maintenance services on a government-owned BD LSRFortessa Flow Cytometer. This contract, valued at $144,941.40, represents the exercise of Option Period One under the original maintenance agreement and extends through August 31,...
- Becton, Dickinson and Company (BD), through its BD Biosciences division, was awarded a $9,126 fixed-price contract with economic price adjustment by the National Cancer Institute for maintenance services on a FACSCalibur 4 CLR flow cytometry instrument (Serial #E1806, Customer Material #343023). The contract represents a Call under a Blanket Purchase Agreement vehicle and covers the period from January 1, 2015 through December 31, 2015, with performance at the National Cancer Institute...
- This federal contract award was made by the National Cancer Institute (NCI), a civilian agency, to Becton, Dickinson and Company (BD), a major medical technology company. The $79,171.34 firm fixed-price purchase order is for an upgrade to a BD Biosciences Fortessa flow cytometer. Flow cytometers are critical instruments used in biomedical research and clinical applications supported by the NCI. This award is associated with a larger BD Biosciences contract vehicle, likely an Indefinite...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for a flow cytometry maintenance agreement. The contract has a ceiling value of $353,344.70 and a period of performance through November 29, 2024. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications, including...
- The National Cancer Institute awarded a $5,185 firm fixed-price Blanket Purchase Agreement (BPA) call to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for the upgrade of an existing LSR Fortress flow cytometry instrument. The contract, issued on July 31, 2015, with an ultimate completion date of August 31, 2015, was performed in Bethesda, Maryland and utilized no small business set-aside designation. This call represents a routine maintenance and...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order contract on October 1, 2004, for flow cytometer service in support of operations at the National Institutes of Health Clinical Center in Bethesda, Maryland. This firm fixed-price delivery order, valued at $38,585, was awarded without a small business set-aside and represents a child contract under BD's larger Indefinite Delivery Vehicle arrangements with NIH. The contract was...